All articles by
FDA approves AstraZeneca- Sanofi’s Beyfortus for RSV LRTD prevention in infants
The US health regulator gave its approval after the Antimicrobial Drugs Advisory Committee (AMDAC) unanimously voted in favour of Beyfortus’ favourable benefit-risk profile
Lilly says donanemab slowed cognitive, functional decline in AD patients in Phase 3 study
In the trial, donanemab lowered the risk of disease progression and half of the participants who were at an earlier stage of the disease and administered with donanemab had no clinical progression at one year
European Health Union: EU steps up action to prevent shortages of antibiotics for next winter
These recommendations, which have been developed through the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), complement the process to develop an EU list of critical medicines
IDTechEx Discusses Applications of Antimicrobial Technology in Addressing Healthcare Infections
Healthcare-associated infections (HAI), also known as hospital-acquired infections, are a major problem healthcare systems face worldwide. Each year, millions of patients contract infectious diseases while in hospital. These HAIs not only lengthen hospital stays and utilize resources, such as hospital beds, but also have deadly consequences. While proper medical practices, such as good hand hygiene, can go a long way, there are additional tools that health systems can use to address this silent pandemic.
Pardes Biosciences Enters into Agreement to be Acquired by MediPacific for between $2.02 and $2.19 in Cash per Share Plus Contingent Value Rights
The disinterested members of the Pardes Board of Directors have unanimously determined that the acquisition by Purchaser is in the best interests of all Pardes stockholders not affiliated with Foresite and have unanimously approved the merger agreement
FDA approves Gilead’s Veklury for Covid-19 treatment in renal impairment patients
The approval was based on findings from a Phase 1 study, as well as results from the Phase 3 REDPINE trial in which Veklury showed a strong PK and safety profile in patients with severe renal impairment
Antengene’s Xpovio gets clearance in Hong Kong for multiple myeloma treatment
Xpovio is said to be the first authorised selective inhibitor of the XPO1 in the world that promotes the intranuclear accumulation and activation of tumour suppressor proteins and growth-regulating proteins
Acumen’s ACU193 shows positive results in Phase 1 study of early Alzheimer’s disease
In the trial, ACU193 met the primary and secondary objectives in both single and multiple doses in 60 participants with early AD and showed a strong safety profile with no adverse events
Bruker Enables Advanced Life-Science and Green-Tech Research in the UK
GHz-Class NMR, Structural Biology assisted by Artificial Intelligence, a New Scientific Software Division and Innovative Helium Solutions at EUROMAR 2023
Deenova’s newest product line, AIDE, pursues successful launch with new contract award at Longjumeau Hospital in France
Deenova, the undisputed leading supplier of innovative pharmacy automation solutions for healthcare facilities, is delighted to announce the recent contract acquisition at Longjumeau Hospital in France, marking another milestone in the successful launch of its cutting-edge product line, AIDE. The contract includes the deployment of one AIDE-CUT, the unparalleled Deenova’s automation robot for medications repackaging in unit dose, and one AIDE-PICK, the most innovative automated patient therapy dispensation robot.